George Papadopoulos
- Infectious Diseases top 5%
- Epidemiology top 10%
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine
- Oncology
- Co-authors
- Amelia LangstonJohn R. PerfectRobert P. DannaMark FriedmanJoseph MenzinJuliana MeyersChristos V. IoannouNikolaos Kontopodis
- Topics
- Antifungal resistance and susceptibility (12 papers)Fungal Infections and Studies (12 papers)Aortic aneurysm repair treatments (9 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
George Papadopoulos
33 papers receiving 551 citations
Peers
Comparison fields: 5 of 85
- Infectious Diseases 290
- Epidemiology 276
- Pulmonary and Respiratory Medicine 133
- Cardiology and Cardiovascular Medicine 97
- Oncology 70
Countries citing papers authored by George Papadopoulos
This map shows the geographic impact of George Papadopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Papadopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Papadopoulos more than expected).
Fields of papers citing papers by George Papadopoulos
This network shows the impact of papers produced by George Papadopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Papadopoulos. The network helps show where George Papadopoulos may publish in the future.
Co-authorship network of co-authors of George Papadopoulos
This figure shows the co-authorship network connecting the top 25 collaborators of George Papadopoulos. A scholar is included among the top collaborators of George Papadopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Papadopoulos. George Papadopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 36 | |
| 6 | 21 | |
| 7 | 15 | |
| 8 | 16 | |
| 9 | 30 | |
| 10 | 6 | |
| 11 | 12 | |
| 12 | 2 | |
| 13 | 37 | |
| 14 | 6 | |
| 15 | 31 | |
| 16 | 45 | |
| 17 | 3 | |
| 18 | 7 | |
| 19 | 121 | |
| 20 | 0 |
About George Papadopoulos
George Papadopoulos is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 36 papers that have together received 562 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (12 papers) and Aortic aneurysm repair treatments (9 papers). The work is most often cited by research in Infectious Diseases (290 citations), Epidemiology (276 citations) and Applied Microbiology and Biotechnology (14 citations). George Papadopoulos has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Amelia Langston, John R. Perfect, Robert P. Danna, Mark Friedman, Joseph Menzin, Juliana Meyers, Christos V. Ioannou, Nikolaos Kontopodis, Amy K. O’Sullivan and Efstratios Apostolakis. Their work appears in journals such as Blood, CHEST Journal and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.